(Q35953773)

11 August 2017

1 reference

title

Challenges facing adjuvants for cancer immunotherapy (English)

1 reference

11 August 2017

1 reference

Circe Mesa

1

1 reference

11 August 2017

Luis E Fernández

series ordinal

2

1 reference

11 August 2017

publication date

1 December 2004

1 reference

Immunology & Cell Biology

11 August 2017

published in

1 reference

11 August 2017

volume

82

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

644-650

1 reference

Mature T cell seeks antigen for meaningful relationship in lymph node

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Danger signals: SOS to the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

BCG immunotherapy of bladder cancer: 20 years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for Th1 induction and dendritic cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

A purified GM3 ganglioside conjugated vaccine induces specific, adjuvant-dependent and non-transient antitumour activity against B16 mouse melanoma in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Vaccination with heat shock protein-peptide complexes: from basic science to clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Immature myeloid cells and cancer-associated immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Dendritic cells: a journey from laboratory to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Dendritic cell vaccines for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Progress in human tumour immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Cytotoxic T lymphocyte activation by cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Heat shock protein 70-associated peptides elicit specific cancer immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Stress proteins and immunity mediated by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

CpG-DNA aided cross-presentation of soluble antigens by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Tumour escape: antitumour effectors too much of a good thing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Regulation of immune responses by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Clinical significance of the determination of angiogenic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

First-line, single-agent Herceptin(trastuzumab) in metastatic breast cancer: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

T regulatory cells 1 inhibit a Th2-specific response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

The Th1-Th2 classification of cellular immune responses: concepts, current thinking and applications in haematological malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

MHC class I antigens, immune surveillance, and tumor immune escape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

INF-gamma rearranges membrane topography of MHC-I and ICAM-1 in colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Regulation of tumour immunity by CD25+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Differentiation of T regulatory cells by immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Driver clones and determinant spreading

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Epitope spreading in immune-mediated diseases: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

Determinant spreading and tumor responses after peptide-based cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01279.X

10.1111/J.0818-9641.2004.01279.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference